Artivion (AORT) News Today $27.41 +0.24 (+0.88%) (As of 10:15 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Artivion, Inc. (NYSE:AORT) Shares Sold by Royce & Associates LPRoyce & Associates LP lessened its holdings in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 13.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 871,170 shares of the company's stock after selling 133,210 shares during the peNovember 16, 2024 | marketbeat.comOppenheimer Issues Positive Forecast for Artivion (NYSE:AORT) Stock PriceNovember 12, 2024 | americanbankingnews.comArtivion, Inc. (AORT) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comArtivion Inc (AORT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic AdvancesNovember 9, 2024 | finance.yahoo.comArtivion price target raised to $32 from $29.60 at LadenburgNovember 9, 2024 | markets.businessinsider.comArtivion (AORT) Gets a Buy from OppenheimerNovember 9, 2024 | markets.businessinsider.comWhere Artivion Stands With AnalystsNovember 8, 2024 | benzinga.comArtivion (NYSE:AORT) Price Target Raised to $32.00 at OppenheimerOppenheimer increased their target price on shares of Artivion from $30.00 to $32.00 and gave the stock an "outperform" rating in a research report on Friday.November 8, 2024 | marketbeat.comArtivion’s Q3 2024: Revenue Growth and Strategic ProgressNovember 8, 2024 | markets.businessinsider.comArtivion’s Strong Financial Performance and Strategic Growth Opportunities Drive Buy RatingNovember 8, 2024 | markets.businessinsider.comArtivion reports Q3 non-GAAP EPS 12c, consensus (6c)November 8, 2024 | markets.businessinsider.comArtivion narrows 2024 revenue view to $389M-$396M from $388M-$396MNovember 8, 2024 | markets.businessinsider.comArtivion Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | prnewswire.comArtivion to Participate in Upcoming Investor ConferencesNovember 5, 2024 | prnewswire.comArtivion (AORT) Scheduled to Post Earnings on ThursdayArtivion (NYSE:AORT) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=432809)October 31, 2024 | marketbeat.comArtivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial ResultsOctober 24, 2024 | prnewswire.comJMP Securities Initiates Coverage of Artivion (AORT) with Market Outperform RecommendationOctober 23, 2024 | msn.comAssessing Artivion: Insights From 6 Financial AnalystsOctober 23, 2024 | benzinga.comArtivion (NYSE:AORT) Shares Gap Up - Here's WhyArtivion (NYSE:AORT) Shares Gap Up - Still a Buy?October 23, 2024 | marketbeat.comArtivion (NYSE:AORT) Now Covered by Analysts at JMP SecuritiesJMP Securities began coverage on shares of Artivion in a report on Wednesday. They issued an "outperform" rating and a $33.00 price target for the company.October 23, 2024 | marketbeat.comArtivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual MeetingOctober 10, 2024 | prnewswire.comArtivion Inc (AORT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...October 9, 2024 | finance.yahoo.comArtivion, Inc. (NYSE:AORT) CAO Amy Horton Sells 12,430 SharesOctober 3, 2024 | insidertrades.comAmy Horton Sells 12,430 Shares of Artivion, Inc. (NYSE:AORT) StockArtivion, Inc. (NYSE:AORT - Get Free Report) CAO Amy Horton sold 12,430 shares of the company's stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $26.18, for a total transaction of $325,417.40. Following the completion of the transaction, the chief accounting officer now owns 139,989 shares of the company's stock, valued at $3,664,912.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.October 2, 2024 | marketbeat.comDimensional Fund Advisors LP Trims Position in Artivion, Inc. (NYSE:AORT)Dimensional Fund Advisors LP decreased its position in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 1.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 1,688,227 shares of the company's stock after selling 25,701 shares during the period. DimenOctober 1, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) Stake Raised by Perceptive Advisors LLCPerceptive Advisors LLC increased its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 4.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,793,703 shares of the company's stock after buyingSeptember 30, 2024 | marketbeat.comBuy Rating for Artivion’s Stock on Promising AMDS Outlook and Financial ImpactSeptember 28, 2024 | markets.businessinsider.comThose who invested in Artivion (NYSE:AORT) a year ago are up 61%September 26, 2024 | finance.yahoo.comFirst Eagle Investment Management LLC Acquires 27,906 Shares of Artivion, Inc. (NYSE:AORT)First Eagle Investment Management LLC grew its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 4.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 598,148 shares of the company's stock aftSeptember 19, 2024 | marketbeat.comAnalyst Scoreboard: 5 Ratings For ArtivionSeptember 16, 2024 | nasdaq.comArtivion (NYSE:AORT) Shares Gap Up Following Analyst UpgradeArtivion (NYSE:AORT) Shares Gap Up Following Analyst UpgradeSeptember 13, 2024 | marketbeat.comIs Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)?September 2, 2024 | finance.yahoo.comShould You Invest in Artivion (AORT)?August 30, 2024 | msn.comArtivion, Inc. (NYSE:AORT) SVP Sells $84,083.85 in StockAugust 30, 2024 | insidertrades.comArtivion, Inc. (NYSE:AORT) SVP Jean F. Holloway Sells 3,167 SharesArtivion, Inc. (NYSE:AORT - Get Free Report) SVP Jean F. Holloway sold 3,167 shares of the business's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $26.55, for a total value of $84,083.85. Following the sale, the senior vice president now directly owns 161,932 shares of the company's stock, valued at approximately $4,299,294.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.August 27, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) VP Matthew A. Getz Sells 9,420 SharesAugust 20, 2024 | insidertrades.comArtivion, Inc. (NYSE:AORT) VP Sells $238,420.20 in StockArtivion, Inc. (NYSE:AORT - Get Free Report) VP Matthew A. Getz sold 9,420 shares of the stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $25.31, for a total value of $238,420.20. Following the completion of the transaction, the vice president now directly owns 34,116 shares in the company, valued at approximately $863,475.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.August 19, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) Short Interest Up 6.2% in JulyArtivion, Inc. (NYSE:AORT - Get Free Report) saw a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 3,270,000 shares, a growth of 6.2% from the July 15th total of 3,080,000 shares. Based on an average daily volume of 235,000 shares, the days-to-cover ratio is presently 13.9 days. Approximately 8.4% of the shares of the stock are sold short.August 18, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) SVP Jean F. Holloway Sells 2,383 SharesAugust 17, 2024 | insidertrades.comAnthony B. Semedo Sells 9,709 Shares of Artivion, Inc. (NYSE:AORT) StockAugust 16, 2024 | insidertrades.comInsider Sale: Director Anthony Semedo Sells 9,709 Shares of Artivion Inc (AORT)August 15, 2024 | finance.yahoo.comArtivion, Inc. (NYSE:AORT) Director Anthony B. Semedo Sells 9,709 SharesArtivion, Inc. (NYSE:AORT - Get Free Report) Director Anthony B. Semedo sold 9,709 shares of the firm's stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $24.99, for a total transaction of $242,627.91. Following the transaction, the director now directly owns 34,159 shares in the company, valued at approximately $853,633.41. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.August 15, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | msn.comTELA Bio, Inc. (TELA) latest stock news & headlines – Yahoo FinanceAugust 11, 2024 | nz.finance.yahoo.comA Look At The Intrinsic Value Of Artivion, Inc. (NYSE:AORT)August 11, 2024 | finance.yahoo.comArtivion, Inc. (AORT) Q2 2024 Earnings Call TranscriptAugust 11, 2024 | seekingalpha.comArtivion, Inc. 2024 Q2 - Results - Earnings Call PresentationAugust 10, 2024 | seekingalpha.comArtivion (NYSE:AORT) Stock Rating Reaffirmed by Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and issued a $30.00 target price on shares of Artivion in a research report on Friday.August 9, 2024 | marketbeat.comAORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q2 2024August 9, 2024 | markets.businessinsider.comArtivion Reports Second Quarter 2024 Financial ResultsAugust 8, 2024 | prnewswire.com Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. AORT Media Mentions By Week AORT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AORT News Sentiment▼1.760.46▲Average Medical News Sentiment AORT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AORT Articles This Week▼12▲AORT Articles Average Week Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Axonics News Today Envista News Today Inari Medical News Today LivaNova News Today TransMedics Group News Today Enovis News Today Soleno Therapeutics News Today Warby Parker News Today iRhythm Technologies News Today CONMED News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AORT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artivion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artivion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
